OQROGet OQRO Pro
Politician trade (House)

Thermo Fisher Scientific (TMO)Rep. Bruce Westerman (AR04) disclosed a sale $1K–$15K

Rep. Bruce Westerman (AR04) disclosed a sale of Thermo Fisher Scientific in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
21 days
Disclosure lag
Traded
Apr 21, 2025
Disclosed
May 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 7, 2024InsiderDirector purchased ~$8.9K of TMO shares in the open market
  2. Dec 9, 2024InsiderDirector purchased ~$2.1K of TMO shares in the open market
  3. Dec 11, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  4. Feb 19, 2025InsiderDirector sold ~$8.4K of TMO shares in the open market
  5. Feb 24, 2025InsiderOfficer sold ~$9.73M of TMO shares in the open market
  6. Feb 25, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  7. Feb 27, 2025FDAFDA device clearance: The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL
  8. Mar 3, 2025InsiderOfficer sold ~$945K of TMO shares in the open market
  9. Mar 3, 2025Congress · 1 personMembers of Congress: 2 purchases
  10. Mar 4, 2025Insider · 1 personInsiders: 9 sales (~$5.2M)
  11. Mar 5, 2025Insider · 1 personInsiders: 8 sales (~$4.2M)
  12. Mar 10, 2025InsiderOfficer sold ~$2.01M of TMO shares in the open market
  13. Mar 27, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  14. Apr 7, 2025Congress · 2 peopleMembers of Congress: 2 sales
  15. Apr 8, 2025Congress · 2 peopleMembers of Congress: 2 sales
  16. Apr 11, 2025Congress · 2 peopleMembers of Congress: 2 sales
  17. Apr 15, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL
  18. Apr 21, 2025 · this disclosureCongressDisclosed sale of TMO — reported range $1,001 - $15,000

What came next

  1. Apr 21, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  2. Apr 28, 2025InsiderOfficer sold ~$129K of TMO shares in the open market
  3. Apr 29, 2025Layoff notice · 100 West Gore Street, ORLANDO, FL, 32806Layoff notice filed in FL: 59 employees
  4. May 5, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  5. May 12, 2025InsiderOfficer sold ~$164K of TMO shares in the open market
  6. May 13, 2025CongressDisclosed purchase of TMO — reported range $15,001 - $50,000
  7. May 15, 2025CongressDisclosed purchase of TMO — reported range $15,001 - $50,000
  8. May 16, 2025CongressDisclosed sale of TMO — reported range $15,001 - $50,000
  9. May 22, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL
  10. Jun 10, 2025CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
  11. Jun 12, 2025FDAFDA device clearance: Thermo Scientific Oxoid Aztreonam/Avibactam Disc (30/20 µg) AZA50
  12. Jun 20, 2025FDAFDA device clearance: The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range…
  13. Jun 30, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
  14. Jul 2, 2025FDAFDA device approval: Oncomine Dx Express Test
  15. Jul 21, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  16. Jul 22, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  17. Jul 25, 2025InsiderOfficer sold ~$192K of TMO shares in the open market
  18. Jul 29, 2025Layoff notice · 5823 Newton Dr Carlsbad CA 92008Layoff notice filed in CA: 52 employees
  19. Jul 29, 2025Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 33 employees
  20. Aug 6, 2025Insider · 1 personInsiders: 15 sales (~$4.5M)
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 93 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 143 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Rep. Bruce Westerman (AR04)

The full history of Rep. Bruce Westerman (AR04) is on the profile page.

How this filing works

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data